1. Introduction
===============

*Goniothalamus* (Family: Annonaceae) is a genus of about 160 species of trees and shrubs mostly found in tropical southeast Asia throughout Indochina and Malaysia \[[@B1-molecules-15-05124]\]. In traditional medicine, different parts of the species are used to treat asthma, rheumatism, fever, malaria, cholera, stomach ache and as post-partum protective remedy, abortifacient and insect repellent \[[@B2-molecules-15-05124]\]. Phytochemical studies on *Goniothalamus*species have resulted in the isolation of various compounds, especially styrylpyrone derivatives, quinoline and isoquinoline alkaloid derivatives and phenantrene lactones, terpenes, acetogenins and flavonoids \[[@B3-molecules-15-05124],[@B4-molecules-15-05124],[@B5-molecules-15-05124],[@B6-molecules-15-05124]\]. Acetogenins and styryl-lactones from *Goniothalamus* species have been shown to be cytotoxic to different human tumor cell lines \[[@B7-molecules-15-05124],[@B8-molecules-15-05124]\]. Other reported biological properties of some compounds of *Goniothalamus* species were inhibition of platelet activating factor (PAF) binding \[[@B9-molecules-15-05124]\], antifungal \[[@B10-molecules-15-05124]\], antiplasmodium and antimycobacterial activities \[[@B11-molecules-15-05124]\].

Recently, the essential oils of *Goniothalamus malayanus, G. macrophyllus, G. uvariodes* and *G. andersonii* have been reported \[[@B12-molecules-15-05124],[@B13-molecules-15-05124]\]. There is limited data on the biological properties of the essential oils of *Goniothalamus* species. A previous study \[[@B14-molecules-15-05124]\] has demonstrated the strong larvicidal activity of *G .andersonii* oil against *Culex quinquefasciatus*, with an LC~50~valueof 60.8 µg/mL. A recent study by Hisham *et al.* \[[@B15-molecules-15-05124]\] showed a broad spectrum antimicrobial activity for the oil of *G. cardiopetalus*. This paper reports for the first time *in vitro* inhibitory effects of the essential oils of five *Goniothalamus*sp. viz, - *G. tapis*, *G. tapisoides*, *G.velutinus, G. woodii*and *G. clemensii* on platelet aggregation and PAF receptor binding.

2. Results and Discussion
=========================

2.1. Chemical analysis
----------------------

Water distillation of the fresh samples of *Goniothalamus* species gave various yields of oils (calculated based on dry weight, [Table 1](#molecules-15-05124-t001){ref-type="table"}). The leaf and bark oils of *G. tapis* and *G .tapisoides* and the bark oil of *G.velutinus* may be considered satisfactory for commercial exploitation due to their high yields (\>2.0%). The oils were analyzed using GC and GC/MS. The list of constituents identified in the oils is shown in order of elution on a DB-5 type column in [Table 2](#molecules-15-05124-t002){ref-type="table"}.

The chemical components of the essential oils of *G. tapis* and *G. tapisoides* have been previously reported by us \[[@B22-molecules-15-05124]\]. The leaf oil of *G. tapis* was made up mainly of sesquiterpenoids with α-copaene (23.8%) and β-caryophyllene (14.4%) as the major components. The bark oil of *G. tapis* could be differentiated from its leaf oil due to its high contents of linalool (13.0%), limonene (12.7%) and safrole (11.2%). As the leaf oil, the root oil of *G. tapis* was also rich in sesquiterpenoids, but different ones were found in this oil, where the most abundant constituent was cyperene (16.2%). The leaf oil of *G. tapisoides* was comprised almost entirely of monoterpenoids, of which 1,8-cineole (79.0%) was the most abundant component. The bark and the root oils of *G. tapisoides* were also rich in 1,8-cineole, but with considerable variation in levels of the minor constituents.

molecules-15-05124-t001_Table 1

###### 

Essential oil yields from different parts of five *Goniothalamus*species.

  Species          Voucher No.   Part used   Yield\* (%)
  ---------------- ------------- ----------- -------------
  *G.tapis*        UM 55095      Leaf        2.23 ± 0.5
                                 Bark        2.85 ± 0.2
                                 Root        0.98 ± 0.4
  *G.tapisoides*   UM 55089      Leaf        3.05 ± 0.2
                                 Bark        3.86 ± 0.5
                                 Root        1.45 ± 0.3
  *G.velutinus*    UM 55097      Bark        1.40 ± 0.3
  *G.clemensii*    UM 55082      Bark        2.80 ± 0.1
  *G.woodii*       UM 55094      Bark        1.80 ± 0.4

\* Yield based on dry weight of the respective plant parts.

The nature of the bark oils of *G. clemensii, G. velutinus* and *G. woodii* is described for the first time as they have not been reported elsewhere. Twenty three (98.1%), 45 (94.0%) and 36 (97.3%) components were identified in the bark oils of *G. clemensii, G. velutinus* and *G. woodii,* respectively. The bark oils were rich in sesquiterpene hydrocarbons and their oxygenated derivatives. A comparison between the oils of these species showed that they possessed some similarity in the composition of sesquiterpenes and sesquiterpenoids although, as one might expect, there were quantitative differences, with considerable variation in levels of the individual constituents of the oils.

The bark oil of *G. clemensii* could be differentiated from the other oils by the absence of monoterpenes and the presence of significantly high concentrations of α-cadinol (41.6%), agarospirol (19.0%), elemol (16.1%) and seychellene (4.0%). Other compounds present in appreciable amounts in the oil were τ-muurolol (3.3%), δ-cadinene (2.7%), β-selinene (2.4%) and trans-α-bergamotene (2.0%). The major components of the bark oil of *C. woodii* were qualitatively similar to that of *C. clemensii* where α-cadinol (21.9%), elemol (12.6%), agarospirol (8.0%), cubenol (4.7%), β-caryophyllene (4.6%), τ-muurolol (4.5%), δ-cadinene (4.6%), cadalene (4.4%), γ-muurolene (3.7%), cyperene (3.7%), β-selinene (2.9%), α-humulene (2.4%), ar-curcumene (2.3%), α-copaene (2.1%) and caryophyllene oxide (2.0%) were the representatives. The bark oil of *G. velutinus*was rich in α-cadinol (14.0%), α-eudesmol (9.7%), τ-muurolol (9.1%), cubenol (7.7%), β-selinene (6.1%), γ-muurolene (5.2%) and δ-cadinene (4.7%). It could be differentiated from the other bark oils by the presence of α-eudesmol and β-bisabolol (1.5%) which were absent in the other oils.

2.2. Inhibition of platelet aggregation
---------------------------------------

The antiplatelet activity of the essential oils of *Goniothalamus* species was determined in human whole blood *in vitro*. In the absence of the essential oils in the whole blood (control, DMSO 0.5%), the inducers, *i.e.,* arachidonic acid (AA), adenosine diphosphate (ADP) and collagen showed 100% platelet aggregation.
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###### 

Percentage composition of the essential oils of selected *Goniothalamus* species.

  Components                          RI a    Percentage (%)^\*^                                                           
  ----------------------------------- ------- -------------------- ------ ------ ------ ------ ------ ------ ------ ------ -------
  Hexanal                             804     \-                   \-     \-     \-     \-     0.3    \-     \-     \-     a,b,c
  α- Pinene                           940     \-                   0.1    0.1    \-     \-     0.7    6.6    4.0    9.6    a,b,c
  Camphene                            953     \-                   \-     \-     \-     0.3    \-     \-     \-     \-     a,b,c
  Benzaldehyde                        962     \-                   \-     \-     \-     0.3    \-     \-     \-     \-     a,b,c
  Sabinene                            975     \-                   \-     \-     \-     \-     0.1    0.3    1.4    0.6    a,b,c
  β-Pinene                            985     \-                   \-     \-     \-     \-     \-     0.1    0.1    0.9    a,b,c
  Myrcene                             992     \-                   \-     \-     \-     \-     \-     1.0    0.6    \-     a,b,c
  α-Phellandrene                      1004    \-                   \-     \-     \-     \-     1.0    0.1    0.1    \-     a,b,c
  p-Cymene                            1022    \-                   \-     \-     3.8    \-     1.0    \-     \-     \-     a,b,c
  p-Menthene                          1027    \-                   \-     \-     \-     \-     \-     6.9    4.2    \-     a,b,c
  Limonene                            1029    \-                   \-     \-     12.7   \-     \-     \-     \-     \-     a,b,c
  β-Phellandrene                      1030    \-                   \-     \-     \-     \-     \-     t      0.1    \-     a,b,c
  δ-3-Carene                          1031    \-                   \-     \-     1.0    \-     \-     \-     \-     \-     a,b,c
  Cineole                             1035                         0.2    0.1    \-     \-     7.6    47.9   56.1   79.0   a,b,c
  (Z)-β-Ocimene                       1038    \-                   \-     \-     \-     \-     \-     0.1    \-     \-     a,b
  (E)-β-Ocimene                       1049    \-                   \-     \-     \-     \-     \-     t      \-     \-     a,b
  γ-Terpinene                         1062    \-                   \-     \-     \-     \-     \-     6.6    5.7    0.2    a,b,c
  *cis*-Sabinene hydrate              1069    \-                   \-     \-     \-     \-     \-     0.12   \-     0.1    a,b
  *cis*-Linalool oxide (furanoid)     1074    \-                   \-     \-     \-     0.4    1.5    \-     \-     \-     a,b
  *trans*-Linalool oxide (furanoid)   1087    \-                   \-     \-     \-     0.4    1.0    \-     \-     \-     a,b
  Terpinolene                         1090    \-                   \-     \-     \-     \-     \-     1.0    1.1    0.1    a,b,c
  p-Cymenene                          1090    \-                   \-     \-     \-     \-     \-     0.4    0.6    t      a,b
  Linalool                            1109                         0.22   0.8    13.0   3.9    18.5   2.3    2.2    1.0    a,b,c
  α-Fenchol                           1118    \-                   \-     \-     \-     \-     \-     0.1    0.1    t      a,b
  *trans*-p-2-Menth-2-en-1-ol         1121    \-                   \-     \-     \-     \-     \-     0.1    0.4    \-     a,b
  *trans*-Pinocarveol                 1140    \-                   \-     \-     \-     \-     \-     \-     \-     0.2    a,b
  Citronellal                         1152    \-                   \-     \-     6.3    \-     \-     \-     \-     \-     a,b,c
  Borneol                             1170    \-                   \-     \-     0.2    \-     \-     \-     \-     0.2    a,b,c
  Terpinen-4-ol                       1174    \-                   1.0           1.5    \-     4.2    22.5   19.6   2.3    a,b,c
  α-Terpineol                         1187    \-                   0.3    0.1    \-     0.1    1.8    2.8    3.2    4.4    a,b,c
  Myrtenol                            1191    \-                   \-     \-     \-     \-     \-     \-     \-     0.1    a,b
  *cis*-Piperitol                     1198    \-                   \-     \-     \-     \-     \-     0.1    0.2    \-     a,b
  α-Fenchyl acetate                   1230    \-                   \-     \-     \-     \-     \-     t      t      t      a,b
  Linalyl acetate                     1257    \-                   \-     \-     1.8    \-     \-     \-     \-     \-     a,b,c
  Geranial                            1266    \-                   \-     \-     0.9    \-     \-     \-     \-     \-     a,b,c
  Safrole                             1287    \-                   \-     \-     11.2   \-     \-     \-     \-     \-     a,b,c
  Bornyl acetate                      1290    \-                   \-     \-     \-     0.4    \-     \-     \-     0.1    a,b,c
  Thymol                              1300    \-                   0.1           \-     \-     \-     \-     \-     \-     a,b,c
  δ-Elemene                           1340    \-                   0.1           \-     0.6    \-     \-     \-     \-     a,b
  Citronellyl acetate                 1352    \-                   \-     \-     1.2    \-     \-     \-     \-     \-     a,b,c
  α-Cubebene                          1354    \-                   \-     0.1    \-     0.9    1.2    t      t      0.1    a,b
  Eugenol                             1359    \-                   \-     \-     2.4    \-     \-     \-     \-     \-     a,b,c
  α-Ylanglene                         1375    \-                   \-     \-     0.8    0.9    \-     \-     \-     \-     a,b
  α-Copaene                           1379    0.4                  1.5    2.1    \-     8.7    23.8   \-     \-     0.1    a,b,c
  Geranyl acetate                     1384    \-                   \-     \-     \-     1.5    \-     \-     \-     \-     a,b,c
  β-Cubebene                          1386    \-                   \-     \-     \-     1.4    \-     \-     \-     \-     a,b
  α-Bourbonene                        1386    0.7                  \-     \-     \-     \-     3.4    \-     \-     \-     a,b
  β-Elemene                           1393    0.1                  0.1    0.8    \-     5.3    1.1    \-     \-     0.1    a,b
  Cyperene                            1401    0.2                  2.9    3.7    \-     16.2   \-     t      t      \-     a,b
  α-Gurjunene                         1412    \-                   \-     \-     \-     \-     0.6    \-     \-     \-     a,b
  α-Cedrene                           1414    \-                   \-     \-     \-     0.8    \-     \-     \-     \-     a,b
  β-Caryophyllene                     1420    \-                   0.6    4.6    2.8    \-     14.2   \-     \-     0.1    a,b,c
  β-Cedrene                           1422    \-                   \-     \-     \-     0.4    \-     \-     \-     \-     a,b
  α-Santalene                         1418    0.5                  0.3    0.2    \-     2.5    \-     \-     \-     \-     a,b
  β-Gurjunene                         1429    \-                   \-     \-     \-     \-     0.6    \-     \-     \-     a,b
  *trans*-α-Bergamotene               1437    2.0                  0.8    0.9    \-     1.4    \-     \-     \-     t      a,b
  α-Guaiene                           1441    \-                                 \-     1.2    \-     \-     \-     \-     a,b
  Aromadendrene                       1442    \-                   \-     \-     \-     1.4    \-     \-     \-     \-     a,b
  (Z)-β-Farnesene                     1442    \-                   \-     \-     0.7    \-     \-     \-     \-     \-     a,b
  epi-β-Santalene                     1453    \-                   0.6    0.2    \-     \-     \-     \-     \-     \-     a,b
  α-Humulene                          1450    0.2                  0.5    2.4    1.9    \-     2.5    \-     \-     \-     a,b,c
  Patchoulene                         1456    \-                   \-     \-     \-     1.8    \-     \-     \-     \-     a,b
  Seychellene                         1464    4.0                  0.5    0.5    \-     \-     \-     \-     \-     \-     a,b
  allo-Aromadendrene                  1462    \-                   \-     \-     \-     \-     3.6    \-     \-     \-     a,b
  β-Chamigrene                        1470    1.3                  \-     \-     \-     \-     \-     \-     \-     \-     a,b
  α-Amorphene                         1474    \-                   1.0    \-     \-            \-     \-     \-     \-     a,b
  γ-Muurolene                         1476                         5.2    3.7                                              a,b
  Germacrene D                        1479    0.2                  \-     1.3    \-     \-     \-     \-     \-     \-     a,b
  ar-Curcumene                        1483    \-                   3.9    2.3    \-     \-     \-     \-     \-     \-     a,b
  β-Selinene                          1488    2.4                  6.1    2.9    \-     1.9    1.6    \-     \-     \-     a,b
  α-Selinene                          1493    \-                   \-     \-     \-     \-     0.5    \-     \-     \-     a,b
  γ-Amorphene                         1498    \-                   \-     \-     \-     5.2    \-     \-     \-     \-     a,b
  Epizonarene                         1503    \-                   \-     \-     \-     2.0    \-     \-     \-     \-     a,b
  α-Muurolene                         1498    \-                   \-     \-     0.3    \-     \-     \-     \-     \-     a,b
  Eremophilene                        1503    \-                   \-     \-     \-     1.6    \-     \-     \-     \-     a,b
  (E,E)-α-Farnesene                   1505    \-                   \-     \-     \-     \-     0.1    \-     \-     \-     a,b
  δ-Amorphene                         1512    \-                   \-     \-     \-     2.5    \-     \-     \-     \-     a,b
  γ- Cadinene                         1513    \-                   0.9    \-     \-     2.3    0.3    \-     \-     0.1    a,b
  δ -Cadinene                         1524    2.7                  4.7    4.6    0.9    3.1    0.7    \-     \-     t      a,b
  *trans*- Calamenene                 1530    \-                   \-     \-     \-     1.1    0.5    \-     \-     0.1    a,b
  Hedycaryol                          1530    \-                   \-     \-     \-     3.4    \-     \-     \-     \-     a,b
  (Z)-Nerolidol                       1533    \-                   \-     \-     0.1    0.4    \-     \-     \-     t      a,b
  *trans*-Cadia-1(2),4-diene          1536    \-                   \-     \-     \-     1.9    \-     \-     \-     \-     a,b
  Eudesma3,7(11)diene                 1545    0.4                  1.0    1.0    \-     \-     \-     \-     \-     \-     a,b
  Elemol                              1549    16.1                 1.4    12.6   3.3    \-     \-     \-     \-     \-     a,b
  Germacrene B                        1560    \-                   0.7    \-     \-     \-     \-     \-     \-     \-     a,b
  (-)-Spathulenol                     1580    0.4                  0.7    0.4    \-     \-     \-     \-     \-     \-     a,b
  Caryophyllene oxide                 1600    0.4                  2.0    2.0    \-     \-     \-     \-     \-     \-     a,b
  Globulol                            1602    0.3                  1.8    0.4    \-     \-     \-     \-     \-     \-     a,b
  Guaiol                              1625    \-                   0.7    \-     \-     \-     \-     \-     \-     \-     a,b
  Viridiflorol                        1610    \-                   0.5    \-     \-     \-     \-     \-     \-     \-     a,b
  τ-Cadinol                           1642    1.0                  2.7    2.2    \-     \-     \-     \-     \-     \-     a,b
  Cubenol                             1647    \-                   7.7    4.7    \-     \-     \-     \-     \-     \-     a,b
  Agarospirol                         1648    19.0                 2.5    8.0    4.5    1.1    \-     \-     \-     \-     a,b
  τ-Muurolol                          1650    3.3                  9.1    4.5    \-     \-     \-     \-     \-     \-     a,b
  β-Eudesmol                          1651    \-                   \-     \-     5.6    5.0    \-     \-     \-     \-     a,b
  α-Eudesmol                          1655    \-                   9.7    \-     5.8    5.7    \-     \-     \-     \-     a,b
  α-Cadinol                           1670    41.6                 14.0   21.9   \-     \-     \-     \-     \-     \-     a,b
  β-Bisabolol                         1677    \-                   1.5    \-     \-     \-     \-     \-     \-     \-     a,b
  Cadalene                            1679    0.8                  2.1    4.4    \-     \-     \-     \-     \-     \-     a,b
  Isolongifolen-5-one                 1717    0.1                  0.4    1.2    \-     \-     \-     \-     \-     \-     a,b
  Eudesm-7(11)-en-4-ol                1705    \-                   1.2    1.0    \-     \-     \-     \-     \-     \-     a,b
  (Z,Z)-Farnesol                      1720    \-                   0.2    0.6    \-     \-     \-     \-     \-     \-     a,b
  (E,Z)-Farnesol                      1750    \-                   0.2           \-     \-     \-     \-     \-     \-     a,b
  1-Octadecene                        1800    \-                   0.3    0.6    \-     \-     \-     \-     \-     \-     a,b
  (E,E) Farnesyl acetate              1819    \-                   0.3           \-     \-     \-     \-     \-     \-     a,b
  Hexadecanoic acid                   1940    \-                   1.6    0.1    \-     \-     \-     \-     \-     \-     a,b
                                      Total   98.1                 93.9   97.0   84.5   88.0   92.4   99.0   99.7   99.4   

Percentages are expressed as peak area normalization on a DB-5 column without correction factor. t = trace, ID methods = identification methods: a = retention index, b = mass spectrum, c = co-chromatography, RI = retention index: measured relative to *n*-alkanes on the DB-5 column; R = root, B = bark, L = leaves.

The % inhibitory effects of the essential oils at 100 µg/mL were determined and those oils which showed more than 50% inhibition were further investigated at various concentrations ([Table 3](#molecules-15-05124-t003){ref-type="table"}). Among the oils tested, the root oil of *G. tapis* and the bark oil of *G. velutinus* showed strong inhibition on platelet aggregation caused by AA, with inhibitory effects of more than 50% at 100 μg/mL. The bark oil of *G. velutinus* also showed strong inhibition on platelet aggregation induced by ADP (51% inhibition).

molecules-15-05124-t003_Table 3

###### 

Percentage inhibition of *Goniothalamus* oils and aspirin on platelet aggregation of human whole blood induced by AA (0.5 mM), collagen (2 μg/mL) and ADP (10 μM).

  Sample            Parts    µg/mL   AA               ADP             Collagen
  ----------------- -------- ------- ---------------- --------------- -------------
  *G. tapis*        Bark     100     35.34 ± 2.9      44.37 ± 4.2     23.49 ± 2.2
  *G. tapis*        *R*oot   100     54.47 ± 1.2 \*   46.79 ± 6.2     22.95 ± 1.7
                             50      38.55 ± 0.6                      
                             25      25.45 ± 0.5                      
                             12.5    16.36 ± 0.7                      
  *G. tapis*        Leaf     100     18.89 ± 1.3      23.80 ± 0.7     18.29 ± 4.5
  *G. tapisoides*   Bark     100     15.62 ± 1.1      37.85 ± 2.9     14.22 ± 4.1
  *G. tapisoides*   Root     100     23.45 ± 2.5      46.75 ± 3.4     30.85 ± 3.6
  *G. tapisoides*   Leaf     100     5.36 ± 0.0       21.46 ± 2.2     21.19 ± 3.9
  *G. velutinus*    Bark     100     53.66 ± 0.3 \*   51.27 ± 0.2\*   32.82 ± 2.8
                             50      32.27 ± 1.4      41.19 ± 0.6     
                             25      17.91 ± 4.0      20.22 ±0.4      
                             12.5    11.03 ± 0.3      13.81 ± 3.4     
  *G. woodii*       Bark     100     42.52 ± 0.7      45.52 ± 3.7     15.27 ± 2.2
  *G. clemensii*    Bark     100     43.62 ± 2.5      28.62 ± 0.7     34.52 ± 0.7
  1,8-Cineol                 100     22.00 ± 7.1      2.3 ± 2.6       12.25 ± 5.0
  Linalool                   100     22.35 ± 5.7      49.88 ± 4.8\*   15.68 ± 0.6
  Safrol                     100     93.40 ± 5.9\*    97.20 ± 1.8\*   
                             50      74.80 ± 0.2      74.35 ± 2.7     
                             25      32.59 ± 6.9      37.15 ± 2.4     
                             12.5    10.53 ± 3.7      20.34 ± 1.8     
  ASA                        25      99.68 ± 0.3      46.84 ± 6.2     35.19 ± 3.1
                             12.5    79.41 ± 2.8                      
                             6.25    62.35 ± 5.3                      
                             3.13    51.76 ± 3.8                      
                             1.56    30.74 ± 0.0                      

Values are presented as mean ± SE (n = 3). \*p \< 0.05 as compare with control. ASA = acetyl salicylic acid.

The oils showed dose-dependent responses, *i.e.,* as the concentration of the oil increased the % inhibition increased. The IC~50~ values of the active oils with mean values of three measurements are shown in [Table 4](#molecules-15-05124-t004){ref-type="table"}. The bark oil of *G. velutinus* was an effective antiplatelet agent as it inhibited both AA and ADP-induced platelet aggregation with IC~50~ values of 93.6 and 87.7 μg/mL, respectively. The root oil of *G. tapis* showed fairly selective inhibitory activity of platelet aggregation induced by AA with an IC~50~ value of 82.3 μg/mL, but not that of other inducers. The IC~50~ values of the oils evaluated were higher than that of acetylsalicylic acid (ASA) (4.5 μg/mL or 24.8 µM), a potent cyclooxygenase inhibitor \[[@B21-molecules-15-05124]\].
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###### 

IC~50~values (µg/mL) of the bark oil of *Goniothalamus velutinus* and the root oil of *G. tapis*, safrole and aspirin on platelet aggregation induced by AA (0.5 mM) and ADP (10 µM) in human whole blood.

  Sample                 AA           ADP
  ---------------------- ------------ ------------
  *G. velutinus*(bark)   93.6 ± 3.1   87.7 ± 4.1
  *G. tapis*(root)       85.3 ± 4.8   ND
  Safrole                33.3 ± 6.2   28.2 ± 1.7
  ASA                    4.5 ± 4.5    ND

Values were calculated from at least three separate experiments. Values are represented as means ± SD. ND = not determined.

In order to correlate the chemical constituents of the oils and their antiplatelet activity, three standard compounds (linalool, cineol and safrole) that are found as major components of some oils, were also investigated for their antiplatelet effects. 1,8-Cineol, the main component of the essential oils of *G. tapisoides* and the leaf oil of *G. tapis* showed weak activity on platelet aggregation caused by all three inducers. Linalool which was present in high concentration in the essential oils of *G. tapis* showed a moderate activity (49.0%) against ADP but a weak activity against AA and collagen-induced aggregation. None of these effects was comparable to those produced by the oils themselves. However, safrole, the main component of the bark oil of *G. tapis*, showed a significant inhibitory effect against AA and ADP-induced aggregation with 93.4% and 97.2% inhibition, respectively ([Table 3](#molecules-15-05124-t003){ref-type="table"}).

Safrole showed a dose-dependent inhibitory effect against AA and ADP-induced aggregation with IC~50~ values of 33.2 and 28.2 µg/mL, respectively. Safrole showed higher activity toward AA and ADP-induced aggregation than the oil itself. These results indicate that the antiplatelet activity of the *Goniothalamus* oils may not be due solely to any individual components but could be due to synergistic effects. A previous study has reported that the antiplatelet and antithrombotic properties *of Lavandula hybrida* oil could be due to the synergistic effect of its components \[[@B23-molecules-15-05124]\].

2.3. Inhibition of PAF receptor binding
---------------------------------------

The bark oils of *G. clemensii*, *G. tapis*, *G.woodii* and *G.velutinus*and the leaf and root oils of *G. tapis* showed strong inhibitory effects on the binding of PAF to receptor on rabbit platelets at 18.2 µg/mL, exhibiting greater than 60% inhibition ([Figure 1](#molecules-15-05124-f001){ref-type="fig"}). The essential oil standards (safrole, 1,8-cineole and linalool) showed weak inhibition on the ^3^H-PAF binding. In the control group (DMSO, 0.1%), ^3^H-PAF showed 100% binding ability to the PAF receptor in rabbit platelets. Cedrol, a known PAF antagonist from natural sources \[[@B24-molecules-15-05124]\] was used as a positive control in the bioassay.

![Inhibitory effects the leaf (L), bark (B) and root (R) oils of *Goniothalamus* and standards (18.2 µg/mL) on ^3^H-PAF binding to PAF receptor on rabbit platelets. Cedrol was used as a positive control. Each point represents the mean of three experiments, each in triplicate. Standard deviation of the mean are indicated as vertical bars. \*p \< 0.05 as compared with the respective control.](molecules-15-05124-g001){#molecules-15-05124-f001}

The percentage inhibitory effects of the active oils at various concentrations are shown in [Figure 2](#molecules-15-05124-f002){ref-type="fig"}. The oils showed dose-dependent responses, *i.e.,* as the concentration of the oil increased the percentage inhibition increased. The IC~50~ values of the active oils with the mean values of three measurements are shown in [Table 5](#molecules-15-05124-t005){ref-type="table"}. Among the oils studied, the bark oil of *G. clemensii* was the most active, with an IC~50~ value of 3.5 µg/mL. The essential oils of *G. tapis* and the bark oils of *G. woodii* and *G. velutinus* showed comparable IC~50~ values, ranging from 5.4 to 10.5 µg/mL, but higher than that of cedrol (IC~50~value = 2.8 µg/mL).

molecules-15-05124-t005_Table 5

###### 

IC~50~ values (µg/mL) of the oils and cedrol on PAF receptor binding to rabbit platelets.

  Oils             Part     IC~50~ (µg/mL)
  ---------------- -------- ----------------
  *G. clemensii*   Bark     3.5 ± 0.2
  *G. tapis*       Leaves   5.4 ± 0.2
                   Bark     7.6 ± 1.2
                   Root     5.5 ± 0.7
  *G. woodii*      Bark     6.5 ± 0.5
  *G. velutinus*   Bark     10.5 ± 1.0
  Cedrol                    2.8 ± 0.7

Values were calculated from at least three separate experiments. Values are represented as means ± SD.

![Inhibitory effect of the leaf (L), bark (B) and root (R) oils of *Goniothalamus tapis*, bark oils of *G. woodii*, *G. clemensii*and *G. velutinus* and cedrol on PAF receptor binding to rabbit platelets. Each point represents the mean of three experiments, each in triplicate. Standard deviation of the mean are indicated as vertical bars.](molecules-15-05124-g002){#molecules-15-05124-f002}

3. Experimental
===============

3.1. Plant material
-------------------

The fresh leaves, bark and roots of *Goniothalamus tapisoides* and bark of *G.velutinus, G.woodii* and *G.clemensii* were collected from the primary forest of Sematan, Sarawak, in October 2006; while *G. tapis* was collected from the forest around Lawas in May 2006. Voucher specimens were deposited at the Herbarium of Universiti Malaysia Sarawak, Kota Samarahan, Sarawak.

3.2. Oil isolation and preparation of samples
---------------------------------------------

The plant materials were subjected to water distillation in Clevenger-type apparatus for 6 h. The oily layers obtained were separated and dried over anhydrous magnesium sulfate. The yields were averaged over three experiments and calculated based on dry weight of the plant materials. The oils were each dissolved in dimethyl sulfoxide (DMSO) (1 mg/50 µL). The stock solutions (10 µL) were diluted in normal saline to give final concentrations of 200, 100, 50 and 25 μg/mL.

3.3. GC and GC-MS analyses
--------------------------

Gas chromatography (GC) and gas chromatography-mass spectrometry (GC-MS) analyses were used for the identification of the essential oil components. The oils were determined using a Shimadzu GC-2010 instrument equipped with a flame ionization detector (FID) and a DB-5 (30 m × 0.25 mm, 1 µm film thickness) capillary column. One µL of each sample, dissolved in ethyl acetate, was injected automatically in spilt mode (Shimadzu AOC-20i auto-injector), using pressure-controlled nitrogen as a carrier gas at a linear velocity of 50 cm^3^/min. The temperature of injector and detector was maintained at 250 ºC. The oven temperature was programmed from 75 ºC for 10 min, then at 3 ºC/min to 250 ºC and held for 5 min. The oils were also examined using stationary phase SE-30 (30 m × 0.25 mm, 0.25 µm film thickness) under the following program condition; initial temperature 60 ºC for 10 min, then 3 ºC/min to 230 ºC for 1 min. Peak areas and retention times were measured by computerized integration. The relative amounts of individual components were calculated based on the peak areas obtained without a flame ionization detector (FID) response factor correction. The linear retention indices of the components relative to n-alkanes were also determined. The oils were also analyzed using a Hewlett Packard GC-MSD 5890 series II. EI electron impact mode with electron energy 70 eV, scan time 1.5 s, mass range 40-500 Da, using a BPX5 (25 m × 0.25 mm × 0.25 µm film thickness) capillary column. Similar condition was used as described in GC programs. Identification of components was by comparing their relative retention indices with those in the literature and their mass spectral data with the existing Wiley library and co-chromatography of some components with authentic components on the DB-5 capillary column \[[@B16-molecules-15-05124]\].

3.4. Platelet aggregation assay
-------------------------------

Collagen, ADP, and AA were products of Chrono-Log Corp. (Havertown, PA, USA). The antiplatelet activity was performed as described by Jantan *et al.* \[[@B18-molecules-15-05124]\]. The use of human blood was approved by the Ethics Committee of Universiti Kebangsaan Malaysia (UKM) (approval no. FF-120-2007). Briefly, blood was taken by venipuncture from healthy human volunteers based on the criteria that that they were non-smokers and had not taken any medications, including aspirin, within the last two weeks, and had not taken any food within the last 8 h. Five µL of each oil or the essential oil standard (safrole, 1,8-cineole and linalool, 20 µg/µL, in DMSO) was added followed by the inducers collagen (2 µg/mL), ADP (10 µM) or AA (0.5 mM). The final concentrations of the sample in the mixture were 100, 50, 25 and 12.5 μg/mL. The platelet aggregation was measured by a Whole Blood Lumi-Aggregometer (Chrono-Log Corp., Havertown, PA) using an electrical impedance method \[[@B19-molecules-15-05124]\]. The mean platelet aggregation in whole blood was measured as a change in impedance over 6 min after the addition of the inducers by comparison to that of a control group impedance \[[@B20-molecules-15-05124]\]. A mixture containing 0.5% DMSO in the diluted whole blood was used as control. Aspirin, a potent cyclooxygenase inhibitor, was used as a positive control in the bioassay \[[@B21-molecules-15-05124]\]. The final concentration of DMSO in the whole blood was 0.5% to eliminate the effect of the solvent on the aggregation \[[@B18-molecules-15-05124]\].

3.5. PAF receptor binding activity
----------------------------------

Radiolabeled PAF (1-O-\[^3^H\]-octadecyl-2-acetyl-sn-glycero-3-phosphocholine was purchased from American Radiolabled Chemicals, (St. Louis, MO, USA) with a specific activity of 60 Ci/mmol soluble in ethanol/toluene (1:1). Unlabeled PAF and cedrol were obtained from Sigma Chemical Co. (St. Louis, MO, USA). The assay was carried out according to the modified method of Valone *et al.* \[[@B17-molecules-15-05124]\]. The use of rabbit blood was approved by the Animal Ethical Committee of UKM (approval no. FSKB/2007/Juriyati/10-July/192). The reaction mixture consisted of 200 μL of washed rabbit platelet suspension, 25 μL of ^3^H-PAF (2.0 nM) with or without 25 μL unlabelled PAF (2.0 µM) and 25 μL of the oil, essential oil standard (safrole, 1,8-cineole and linalool) or control solution. The final concentrations of the oil sample or standard in the reaction mixtures were 18.2, 9.1, 4.5, 2.3 μg/mL. The final concentration of DMSO (control) in the reaction mixture was fixed at 0.1% to avoid interference with the receptor binding studies. The reaction mixture with 0.1% DMSO in saline was used as a control and cedrol was used as a positive control. The reaction mixture was incubated at room temperature for 1 h. The free and bound ligands were separated by filtration technique using Whatman GF/C glass fibre filters. The radioactivity was measured by scintillation counter (Packard Tri-Carb, models 2100TR/2300TR, Germany). The difference between the total amounts of ^3^H-PAF bound in the absence and in the presence of excess unlabelled PAF was defined as specific binding of ^3^H-PAF. The specific binding is expressed is expressed as percent inhibition of the control. The IC~50~ values of the samples were obtained from at least three independent determinations.

3.6. Statistical analysis
-------------------------

All the data were analysed using *Statistical Package for Social Sciences* (SPSS) version 15.0. Each sample was measured in triplicate and the data are presented as means ± standard deviation (SD). Probit programme was used to determine the IC~50~ value for active extract. The values were obtained from at least three determinations. Data were analysed using a one way analysis of variance (ANOVA) for multiple comparisons. p \< 0.05 was considered to be statistically significant.

4. Conclusions
==============

A chemical composition-PAF antagonistic activity analysis demonstrates that the strong PAF antagonistic activity of the active *Goniothalamus* sp. oils is related to their high contents of sesquiterpenes and sesquiterpenoids, although other constituents may also contribute to the activity of the oils ([Table 2](#molecules-15-05124-t002){ref-type="table"} and [Figure 1](#molecules-15-05124-f001){ref-type="fig"}). It is difficult to correlate the activity of any oil with its individual components as these components could possibly produce a synergistic effect on the overall PAF antagonistic activity of the oils. The inhibitory activity may be due to the different modes of action of the total components of the oils towards PAF receptor binding. Further studies need to be carried out to identify the active compounds in *Goniothalamus* oils and to find the lead structure with maximum inhibitory activity.
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